Company Filing History:
Years Active: 2005-2008
Title: The Innovative Contributions of Robert W. Wannemacher
Introduction
Robert W. Wannemacher is a prominent inventor based in Frederick, MD, whose work has significantly contributed to the field of immunology. With a total of three patents to his name, he is recognized for his innovative approaches to vaccine development, particularly in relation to ricin toxin.
Latest Patents
Among his most recent patents, Wannemacher has developed a ricin toxin A-chain fragment for use as a vaccine. This invention involves polypeptides and variants that maintain substantial identity to ricin A chain while lacking or exhibiting reduced activity compared to controls. This significant advancement boasts increased solubility in physiological conditions while preserving the necessary immunological epitope integrity of the wild type ricin toxin A chain. Additionally, he has patented a deglycosylated ricin toxin A-chain vaccine, which also encompasses methods for its preparation and application, marking a critical step in the prevention and treatment of ricin intoxication.
Career Highlights
Wannemacher serves as an inventor for the U.S. Government, specifically representing the Secretary of the Army. His work in this capacity demonstrates his commitment to advancing military healthcare and protection against biological threats. His research may play a vital role in enhancing troop safety and preparedness against potential ricin exposure.
Collaborations
Throughout his career, Robert has collaborated with fellow inventors Mark A. Olson and Charles B. Millard, pooling their expertise to further innovate in the realm of vaccine development and related research efforts. These collaborations underscore the importance of teamwork in scientific advancements and the sharing of knowledge and resources.
Conclusion
In conclusion, Robert W. Wannemacher's contributions to the field of immunology, particularly through his patents related to ricin toxin vaccines, highlight his role as a key innovator. His work is essential in the ongoing battle against bioterrorism and infectious diseases, benefiting both military personnel and civilian populations alike.